Biology subjects

Fex, M.

Publications and source records attributed to Fex, M..

4 recordsLinked to original sources

bioRxiv2025

Lysine Potentiates Insulin Secretion via AASS-Dependent Catabolism and Regulation of GABA Content and Signaling

Background and aimLysine is an essential amino acid with insulinotropic effects in humans. In vitro, lysine also potentiates glucose-stimulated insulin secretion (GSIS) in {beta} cell lines and rodent pancreatic islets. For decades it has been assumed that insulinotropic action of lysine is mediated by plasma membrane depolarization similar to arginine. Aminoadipate-Semialdehyde Synthase (AASS) is a mitochondrial-located bifunctional enzyme engaged in the first two steps of the lysine catabolism. Whether AASS-dependent lysine catabolism occurs in {beta} cells and whether it is required for its insulinotropic action has not been investigated. MethodsmRNA expression of lysine catabolism pathway genes was assessed in human islets from non-diabetic (ND) and type 2 diabetes (T2D) subjects. AASS was silenced in human pancreatic islets and in INS1 832/13 {beta} cells. {beta} cell metabolism and function were investigated by ELISA, extracellular flux analysis, live cell calcium imaging, transcriptomics and metabolomics analyses. ResultsExpression of genes involved in lysine catabolism, including AASS, ALDH7A1, DHTKD1 and HADH, was reduced in pancreatic islets from T2D donors. Silencing of AASS resulted in reduced lysine- and glucose-stimulated insulin secretion in human islets and INS1 832/13 {beta} cells. Surprisingly, transcriptomics and metabolomics analysis in Aass-KD {beta} cells with suppressed lysine catabolism identified reduced {gamma}-aminobutyric acid (GABA)/glutamate ratio as well as altered expression of genes implicated in GABA metabolism. This was accompanied by altered mitochondrial TCA cycle and oxidative phosphorylation (OXPHOS) activity, reflected by elevated lactate/pyruvate and reduced whole-cell ATP/ADP content as well as ATP-linked mitochondrial respiration. Glucose-and GABA-stimulated cytosolic calcium was also altered in Aass-KD {beta} cells. Strikingly, addition of GABA recovered impaired insulin secretion in Aass-KD {beta} cells. ConclusionAASS-dependent lysine catabolism is required to maintain adequate GABA shunt metabolism and signaling. In addition, lysine catabolism supports mitochondrial energy production, calcium uptake and insulin secretion. Reduced AASS-dependent lysine catabolism may contribute to {beta} cell GABA depletion and dysfunction in T2D patients.

cell biology↗

bioRxiv2024

Modelling genetic risk of β-cell dysfunction in human induced pluripotent stem cells from patients carrying the MTNR1B risk variant.

Disruptions in circadian rhythm, partly controlled by the hormone melatonin, increase the risk of type 2 diabetes (T2D). Accordingly, a variant of the gene encoding the melatonin receptor 1B (MTNR1B) is robustly associated with increased risk of T2D. This single nucleotide polymorphism (SNP; rs10830963; G-allele) is an expression quantitative trait locus (eQTL) in human pancreatic islets, conferring increased expression of MTNR1B, which is thought to perturb pancreatic {beta}-cell function. To understand this pathogenic mechanism in detail, we utilized human induced pluripotent stem cells (hiPSC), derived from individuals with T2D carrying the MTNR1B G-allele. Patient-derived fibroblasts were reprogrammed to hiPSC and single-base genome editing by CRISPR/Cas9 was employed to create isogenic lines of either the C/C or G/G genotypes (non-risk and risk, respectively). In addition, the human embryonic stem cell (hESC) line (HUES4) was subjected to genome editing to create isogenic lines of either the C/C or G/G genotypes. hiPSC and hESC were differentiated into {beta}-cells, using a 50-day 2D protocol. Single-base genome editing generated cells with the desired genotype at a success rate of >90%. Expression of stage-specific markers confirmed differentiation of both hiPSC and hESC into {beta}-cells. MTNR1B mRNA levels were consistently low in differentiated {beta}-cells, precluding quantitative analysis of gene expression. However, Western blot analysis showed higher levels of MTNR1B in differentiated {beta}-cells carrying the risk allele, consistent with rs10830963 (G-allele) being an eQTL in {beta}-cells. Insulin secretion in response to glucose and IBMX was similar between the genotypes, whereas addition of melatonin reduced secretion in G-allele carriers. We conclude that the stem cell-derived {beta}-cells are not sufficiently mature to allow determination of eQTL status at the mRNA level. However, we did observe increased MTNR1B protein and increased sensitivity of {beta}-cells from risk allele carriers (G-allele) to melatonin with regard to insulin secretion, thus supporting a functional role for the rs10830963 SNP in {beta}-cell dysfunction.

cell biology↗

bioRxiv2020

DIMT1, a regulator of ribosomal biogenesis, controls beta-cell protein synthesis, mitochondrial function and insulin secretion

We previously reported that transcription factor B1 mitochondrial (TFB1M) is involved in the pathogenesis of type 2 diabetes (T2D) owing to mitochondrial dysfunction. Here, we describe that dimethyladenosine transferase 1 homolog (DIMT1), a homologue of TFB1M, is expressed and active in pancreatic {beta}-cells. Like TFB1M, it has been implicated in control of ribosomal RNA (rRNA) but its role in {beta}-cells or T2D remains to be identified. Silencing of DIMT1 impacted mitochondrial function, leading to reduced expression of mitochondrial OXPHOS proteins, reduced oxygen consumption rate (OCR), dissipated mitochondrial membrane potential ({Delta}{Psi}m) and caused a lower rate of ATP production (mATP). In addition, DIMT1 knockdown slowed the rate of protein synthesis. In accordance with these findings, DIMT1-deficiency perturbed insulin secretion in rodent and human {beta}-cell lines. These effects are likely a result of destabilization of ribosomal assembly, involving NIN1 (RPN12) binding protein 1 homolog (NOB-1) and Pescadillo ribosomal biogenesis factor 1 (PES-1). These are two critical ribosomal subunits proteins, whose interactions were perturbed upon DIMT1-deficiency, thereby disturbing protein synthesis in {beta}-cells. Thus, we have here highlighted a role of DIMT1 in ribosomal biogenesis that perturbs protein synthesis, resulting in mitochondrial dysfunction and disrupted insulin secretion, both being potential pathogenetic factors in T2D.

molecular biology↗

bioRxiv2019

Mitochondrial clearance of Ca2+ controls insulin secretion

Transport of Ca2+ from the cytosol to the mitochondrial matrix of insulin-secreting pancreatic {beta}-cells facilitates nutrient-mediated insulin secretion. However, the underlying mechanism is unclear. The establishment of the molecular identity of the mitochondrial Ca2+ uniporter (MCU) and associated proteins has allowed mitochondrial Ca2+ transport to be modified in intact cells. We examined the consequences of deficiency of the accessory protein, MICU2, in rat and human insulin-secreting cell lines as well as in mouse islets. Glucose-induced mitochondrial Ca2+ elevation and inner membrane hyperpolarization were reduced, together with cytosolic ATP/ADP-ratios and insulin secretion. Insulin secretion in Micu2 knock out mice was attenuated in vitro as well as in vivo. While KCl-evoked sub-plasmalemmal Ca2+ increases were more pronounced, the global cytosolic Ca2+ response was, surprisingly, diminished in MICU2-deficient cells. These findings were supported by selective inhibition of mitochondrial Ca2+ uptake by mitochondrial depolarization. It is concluded that mitochondrial Ca2+ transport plays an additional and hitherto unrecognized role in stimulated {beta}-cells by regulating net Ca2+ entry across the plasma membrane. This is likely accounted for by clearing of sub-plasmalemmal Ca2+ levels by mitochondria located near the plasma membrane.

molecular biology↗